Atlas Trials

Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia

Clinical trial NCT03504644 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03504644
Sponsor
ECOG-ACRIN Cancer Research Group
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent Adult Lymphoblastic LymphomaRecurrent B Acute Lymphoblastic LeukemiaRecurrent B Lymphoblastic LymphomaRecurrent T Acute Lymphoblastic LeukemiaRecurrent T Lymphoblastic LymphomaRefractory B Acute Lymphoblastic LeukemiaRefractory B Lymphoblastic LymphomaRefractory T Acute Lymphoblastic LeukemiaRefractory T Lymphoblastic Lymphoma
Start date
2018-08-13
Primary completion
2025-07-22
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.